Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Journal for Immunotherapy of Cancer
|
April 22, 2021
Short-course IL-15 given as a continuous infusion led to a massive expansion of effective NK cells: implications for combination therapy with antitumor antibodies
Sigrid P Dubois, Milos D Miljkovic, Thomas A Fleisher, et al.
Blood Advances
|
January 14, 2022
Triple combination of BET plus PI3K and NF-κB inhibitors exhibit synergistic activity in adult T-cell leukemia/lymphoma
Anusara Daenthanasanmak, Richard N Bamford, Makoto Yoshioka, et al.
Blood Advances
|
March 4, 2026
A phase 1 trial of romidepsin, azacitidine, dexamethasone and lenalidomide in relapsed or refractory T-cell lymphoma
Max J Gordon, Milos D Miljkovic, Paige Milhon, et al.
Haematologica
|
May 12, 2018
End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making
Christopher Melani, Ranjana Advani, Mark Roschewski, et al.
Blood
|
August 31, 2019
Rapid progression of adult T-cell leukemia/lymphoma as tumor-infiltrating Tregs after PD-1 blockade
Daniel A Rauch, Kevin C Conlon, Murali Janakiram, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
April 11, 2020
<sup>90</sup>Y-Daclizumab (Anti-CD25), High-Dose Carmustine, Etoposide, Cytarabine, and Melphalan Chemotherapy and Autologous Hematopoietic Stem Cell Transplant Yielded Sustained Complete Remissions in 4 Patients with Recurrent Hodgkin's Lymphoma
Kevin C Conlon, Claude Sportes, Martin W Brechbiel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 31, 2019
IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion
Kevin C Conlon, E Lake Potter, Stefania Pittaluga, et al.
Nature Medicine
|
January 9, 2026
BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial
Tuan Vu, Hacer Durmus, Michael Rivner, et al.
Nature Biomedical Engineering
|
November 29, 2025
mRNA engineering of allogeneic mesenchymal stem cells enables coordinated delivery of T cell engagers and immunotherapeutic cues
C Andrew Stewart, Shaji Daniel, Elizabeth J Curvino, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Journal for Immunotherapy of Cancer
|
April 22, 2021
Short-course IL-15 given as a continuous infusion led to a massive expansion of effective NK cells: implications for combination therapy with antitumor antibodies
Sigrid P Dubois, Milos D Miljkovic, Thomas A Fleisher, et al.
Blood Advances
|
January 14, 2022
Triple combination of BET plus PI3K and NF-κB inhibitors exhibit synergistic activity in adult T-cell leukemia/lymphoma
Anusara Daenthanasanmak, Richard N Bamford, Makoto Yoshioka, et al.
Blood Advances
|
March 4, 2026
A phase 1 trial of romidepsin, azacitidine, dexamethasone and lenalidomide in relapsed or refractory T-cell lymphoma
Max J Gordon, Milos D Miljkovic, Paige Milhon, et al.
Haematologica
|
May 12, 2018
End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making
Christopher Melani, Ranjana Advani, Mark Roschewski, et al.
Blood
|
August 31, 2019
Rapid progression of adult T-cell leukemia/lymphoma as tumor-infiltrating Tregs after PD-1 blockade
Daniel A Rauch, Kevin C Conlon, Murali Janakiram, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
April 11, 2020
<sup>90</sup>Y-Daclizumab (Anti-CD25), High-Dose Carmustine, Etoposide, Cytarabine, and Melphalan Chemotherapy and Autologous Hematopoietic Stem Cell Transplant Yielded Sustained Complete Remissions in 4 Patients with Recurrent Hodgkin's Lymphoma
Kevin C Conlon, Claude Sportes, Martin W Brechbiel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 31, 2019
IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion
Kevin C Conlon, E Lake Potter, Stefania Pittaluga, et al.
Nature Medicine
|
January 9, 2026
BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial
Tuan Vu, Hacer Durmus, Michael Rivner, et al.
Nature Biomedical Engineering
|
November 29, 2025
mRNA engineering of allogeneic mesenchymal stem cells enables coordinated delivery of T cell engagers and immunotherapeutic cues
C Andrew Stewart, Shaji Daniel, Elizabeth J Curvino, et al.
Page
of 2